Publications by authors named "Keith A Rodvold"

Claim this Profile
P
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.
Keith A Rodvold, Mark H Gotfried, Philip Sabato, Tim Henkel, Paul C McGovern

Antimicrob Agents Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.
Thomas P Lodise, Anita F Das, Niels Frimodt-Møller, Kalpana Gupta, Keith A Rodvold

Clin Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.
Keith A Rodvold, Mark H Gotfried, Xilla T Ussery, Shekman L Wong, Kamal A Hamed

Antimicrob Agents Chemother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons Are Still Being Learned about Intrapulmonary Antibiotic Concentrations.
Keith A Rodvold, Andrew F Shorr

Am J Respir Crit Care Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Michael J Satlin, David van Duin, Pranita D Tamma, Thomas P Lodise, Daria Van Tyne, Keith A Rodvold

Clin Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
Keith A Rodvold, Justin Bader, Jon B Bruss, Kamal Hamed

Antimicrob Agents Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Keith A Rodvold, Mark H Gotfried, Vipul Gupta, Amanda Ek, Praveen Srivastava

Antimicrob Agents Chemother· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
Gina Patel, Keith A Rodvold, Vipul K Gupta, Jon Bruss, Leanne Gasink

Antimicrob Agents Chemother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to De Sutter, De Waele, and Vermeulen: "Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update".
Emily N Drwiega, Keith A Rodvold

Clin Pharmacokinet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update.
Emily N Drwiega, Keith A Rodvold

Clin Pharmacokinet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questions on Vancomycin Dosing.
Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Keith A Rodvold

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
Takayuki Katsube, David P Nicolau, Keith A Rodvold, Richard G Wunderink, Roger Echols

J Antimicrob Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
Takayuki Katsube, David P Nicolau, Keith A Rodvold, Richard G Wunderink, Roger Echols

J Antimicrob Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.
Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Keith A Rodvold

Am J Health Syst Pharm· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Keith A Rodvold

Clin Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Keith A Rodvold

Am J Health Syst Pharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
60 Plus Years Later and We Are Still Trying to Learn How to Dose Vancomycin.
Keith A Rodvold

Clin Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics.
Keith A Rodvold, Rodrigo M Burgos, Xing Tan, Manjunath P Pai

Clin Pharmacokinet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Keith A Rodvold

Pharmacotherapy· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Jason M Pogue, Ronald N Jones, John S Bradley, David R Andes, Sujata M Bhavnani, Keith A Rodvold

Antimicrob Agents Chemother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline.
Keith A Rodvold, Manjunath P Pai

Clin Infect Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis.
Mike Sharland, Keith A Rodvold, Hal R Tucker, Nathalie Baillon-Plot, Margaret Tawadrous

Pediatr Infect Dis J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omadacycline: a novel aminomethylcycline.
Rodrigo M Burgos, Keith A Rodvold

Infect Drug Resist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
Rodrigo M Burgos, Keith A Rodvold

Future Microbiol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: lefamulin and pharmacokinetic/pharmacodynamic rationale to support the dose selection of lefamulin.
Keith A Rodvold

J Antimicrob Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis